FDA authorizes Pfizer/BioNTech Covid-19 vaccine boosters for 16- and 17-year-olds
Published
Dec 09 2021 at 4:43 PM GMT
Key
Points
Points
- The US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17.
-
Posted in Top Stories
Trending
Stats
- Published Dec 9, 2021 4:43 PM GMT